Skadden Reps Mylan In $1.6B Buy Of Indian Generics Maker
Mylan Inc. has agreed to purchase a generic-drug maker from Indian pharmaceutical giant Strides Arcolab Ltd. for $1.6 billion, giving it access to a complementary portfolio and emerging markets worldwide, the...To view the full article, register now.
Already a subscriber? Click here to view full article